Elder Granger - 27 Jul 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 27 Jul 2023
Net transaction value: +$25,000
SEC form: 4
Accepted by SEC: 31 Jul 2023, 07:58:49 UTC
Prior SEC filing: 09 Jun 2023
Next SEC filing: 03 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Mark Heinen, Attorney-in-Fact

Key filing fact

Elder Granger filed Form 4 for Better Therapeutics, Inc. on 31 Jul 2023.

Key facts

This page summarizes Elder Granger's Form 4 filing for Better Therapeutics, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 Jul 2023, 07:58.

Change

Previous filing in this sequence was filed on 09 Jun 2023.
Current net transaction value: +$25,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BTTX transaction

Common Stock

Purchase

Transaction value: $25,000
Shares: +34,251
Change %: +2141%
Price: $0.7299
Shares after: 35,851
Date: 27 Jul 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.

Footnote F2

As one of the PIPE Investors, the Reporting Person acquired 34,251 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.